Combating Illicit Xylazine Act
This bill regulates xylazine under the Controlled Substances Act (CSA). Xylazine, also known as tranq , is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine. This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused. Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA. The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife programs. The bill also exempts xylazine manufacturers from the CSA's physical security requirements. Finally, the bill requires the DEA, in coordination with the Food and Drug Administration, to report on (1) the prevalence and impact of illicit xylazine use in the United States, and (2) updated information on the prevalence and proliferation of xylazine trafficking and misuse in the United States.
L2 verified 0
XML scalars
+
- congress
- 119
- type
- HR
- number
- 1266
- originChamber
- House
- originChamberCode
- H
- introducedDate
- 2025-02-12
- updateDate
- 2026-10-31T02:42:10Z
- updateDateIncludingText
- 2026-10-31T02:42:10Z
- title
- Combating Illicit Xylazine Act
- legislationUrl
- https://www.congress.gov/bill/119th-congress/house-bill/1266
Constitutional authority statement (CDATA)
+
[Congressional Record Volume 171, Number 29 (Wednesday, February 12, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. PANETTA:H.R. 1266.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 18[Page H678]
Pipeline
+
Sponsor
+
- Rep. Panetta, Jimmy [D-CA-19] · [D-CA-19] · P000613
Sponsor record (congress_legislators)
+
Bio (legislators)
+
Current term (5 total)
+
Leadership roles (0)
+
Committee memberships (3)
+
Social media
+
- Twitter: @RepJimmyPanetta
- Facebook: @RepJimmyPanetta
- Instagram: @repjimmypanetta
District offices (4)
+
- 701 Ocean St., Room 318C, Santa Cruz, CA, 95060 · 831-429-1976 · fax 831-424-7099 · 36.9778501,-122.0226351
- 800 Pine Street, Paso Robles, CA, 93446 · 805-400-6535 · 35.6226739,-120.6877702
- 1200 Aguajito Road, Suite 003, Monterey, CA, 93940 · 831-424-2229 · 36.5896723,-121.8806174
- 841 Blossom Hill Road, Suite 209, San Jose, CA, 95123 · 408-960-0333 · 37.2506145,-121.8554964
Other names (0)
+
Sponsor FEC record (fec_live)
+
Candidate record (candidates) · cycle 2026
+
Candidate summary (candidate_summaries) · cycle 2026
+
Connected committees (0)
+
Cosponsors (114)
+
- Rep. Pfluger, August [R-TX-11] · [R-TX-11] · P000048 · Co-sponsored 2025-02-12 · original
- Rep. Bilirakis, Gus M. [R-FL-12] · [R-FL-12] · B001257 · Co-sponsored 2025-02-12 · original
- Rep. Pappas, Chris [D-NH-1] · [D-NH-1] · P000614 · Co-sponsored 2025-02-12 · original
- Rep. Fitzgerald, Scott [R-WI-5] · [R-WI-5] · F000471 · Co-sponsored 2025-02-12 · original
- Rep. Ross, Deborah K. [D-NC-2] · [D-NC-2] · R000305 · Co-sponsored 2025-02-12 · original
- Rep. Crenshaw, Dan [R-TX-2] · [R-TX-2] · C001120 · Co-sponsored 2025-02-12 · original
- Rep. Harder, Josh [D-CA-9] · [D-CA-9] · H001090 · Co-sponsored 2025-02-12 · original
- Rep. DelBene, Suzan K. [D-WA-1] · [D-WA-1] · D000617 · Co-sponsored 2025-02-12 · original
- Rep. Miller-Meeks, Mariannette [R-IA-1] · [R-IA-1] · M001215 · Co-sponsored 2025-02-12 · original
- Rep. Pettersen, Brittany [D-CO-7] · [D-CO-7] · P000620 · Co-sponsored 2025-02-12 · original
- Rep. Clarke, Yvette D. [D-NY-9] · [D-NY-9] · C001067 · Co-sponsored 2025-02-12 · original
- Rep. Deluzio, Christopher R. [D-PA-17] · [D-PA-17] · D000530 · Co-sponsored 2025-02-12 · original
- Rep. Magaziner, Seth [D-RI-2] · [D-RI-2] · M001223 · Co-sponsored 2025-02-12 · original
- Rep. Bacon, Don [R-NE-2] · [R-NE-2] · B001298 · Co-sponsored 2025-02-12 · original
- Rep. Obernolte, Jay [R-CA-23] · [R-CA-23] · O000019 · Co-sponsored 2025-02-12 · original
- Rep. Costa, Jim [D-CA-21] · [D-CA-21] · C001059 · Co-sponsored 2025-02-12 · original
- Rep. Balderson, Troy [R-OH-12] · [R-OH-12] · B001306 · Co-sponsored 2025-02-12 · original
- Rep. Barragán, Nanette Diaz [D-CA-44] · [D-CA-44] · B001300 · Co-sponsored 2025-02-12 · original
- Rep. Ciscomani, Juan [R-AZ-6] · [R-AZ-6] · C001133 · Co-sponsored 2025-02-12 · original
- Rep. Carey, Mike [R-OH-15] · [R-OH-15] · C001126 · Co-sponsored 2025-02-12 · original
- Rep. Bice, Stephanie I. [R-OK-5] · [R-OK-5] · B000740 · Co-sponsored 2025-02-12 · original
- Rep. Craig, Angie [D-MN-2] · [D-MN-2] · C001119 · Co-sponsored 2025-02-12 · original
- Rep. Norcross, Donald [D-NJ-1] · [D-NJ-1] · N000188 · Co-sponsored 2025-02-12 · original
- Rep. Fong, Vince [R-CA-20] · [R-CA-20] · F000480 · Co-sponsored 2025-02-12 · original
- Rep. Tenney, Claudia [R-NY-24] · [R-NY-24] · T000478 · Co-sponsored 2025-02-12 · original
- Rep. Fitzpatrick, Brian K. [R-PA-1] · [R-PA-1] · F000466 · Co-sponsored 2025-02-12 · original
- Rep. Burchett, Tim [R-TN-2] · [R-TN-2] · B001309 · Co-sponsored 2025-02-12 · original
- Rep. Dean, Madeleine [D-PA-4] · [D-PA-4] · D000631 · Co-sponsored 2025-02-12 · original
- Rep. Cohen, Steve [D-TN-9] · [D-TN-9] · C001068 · Co-sponsored 2025-02-12 · original
- Rep. Davis, Donald G. [D-NC-1] · [D-NC-1] · D000230 · Co-sponsored 2025-02-12 · original
- Rep. Correa, J. Luis [D-CA-46] · [D-CA-46] · C001110 · Co-sponsored 2025-02-12 · original
- Rep. Webster, Daniel [R-FL-11] · [R-FL-11] · W000806 · Co-sponsored 2025-02-12 · original
- Rep. Collins, Mike [R-GA-10] · [R-GA-10] · C001129 · Co-sponsored 2025-02-12 · original
- Rep. Suozzi, Thomas R. [D-NY-3] · [D-NY-3] · S001201 · Co-sponsored 2025-02-12 · original
- Rep. Harshbarger, Diana [R-TN-1] · [R-TN-1] · H001086 · Co-sponsored 2025-02-12 · original
- Rep. Salinas, Andrea [D-OR-6] · [D-OR-6] · S001226 · Co-sponsored 2025-02-14
- Rep. Lee, Laurel M. [R-FL-15] · [R-FL-15] · L000597 · Co-sponsored 2025-02-14
- Rep. Wittman, Robert J. [R-VA-1] · [R-VA-1] · W000804 · Co-sponsored 2025-02-14
- Rep. Mann, Tracey [R-KS-1] · [R-KS-1] · M000871 · Co-sponsored 2025-02-14
- Rep. Soto, Darren [D-FL-9] · [D-FL-9] · S001200 · Co-sponsored 2025-02-14
- Rep. Cherfilus-McCormick, Sheila [D-FL-20] · [D-FL-20] · C001127 · Co-sponsored 2025-02-24Dem-FL-20 current · 3 terms
- Rep. Haridopolos, Mike [R-FL-8] · [R-FL-8] · H001099 · Co-sponsored 2025-02-24
- Rep. Sewell, Terri A. [D-AL-7] · [D-AL-7] · S001185 · Co-sponsored 2025-02-24
- Rep. Rulli, Michael A. [R-OH-6] · [R-OH-6] · R000619 · Co-sponsored 2025-02-24Rep-OH-6 current · 2 terms · 2 district offices
- Rep. Finstad, Brad [R-MN-1] · [R-MN-1] · F000475 · Co-sponsored 2025-02-25
- Rep. Davids, Sharice [D-KS-3] · [D-KS-3] · D000629 · Co-sponsored 2025-02-25
- Rep. Yakym, Rudy [R-IN-2] · [R-IN-2] · Y000067 · Co-sponsored 2025-02-25
- Rep. Self, Keith [R-TX-3] · [R-TX-3] · S001224 · Co-sponsored 2025-03-03
- Rep. Harris, Andy [R-MD-1] · [R-MD-1] · H001052 · Co-sponsored 2025-03-03
- Rep. Calvert, Ken [R-CA-41] · [R-CA-41] · C000059 · Co-sponsored 2025-03-03
- Rep. Johnson, Dusty [R-SD-At Large] · [R-SD-0] · J000301 · Co-sponsored 2025-03-03
- Rep. Kelly, Robin L. [D-IL-2] · [D-IL-2] · K000385 · Co-sponsored 2025-03-05
- Rep. Steil, Bryan [R-WI-1] · [R-WI-1] · S001213 · Co-sponsored 2025-03-05
- Rep. Vindman, Eugene [D-VA-7] · [D-VA-7] · V000138 · Co-sponsored 2025-03-25
- Rep. McDowell, Addison [R-NC-6] · [R-NC-6] · M001240 · Co-sponsored 2025-03-31
- Rep. Sorensen, Eric [D-IL-17] · [D-IL-17] · S001225 · Co-sponsored 2025-04-24
- Rep. Auchincloss, Jake [D-MA-4] · [D-MA-4] · A000148 · Co-sponsored 2025-05-29
- Rep. Van Drew, Jefferson [R-NJ-2] · [R-NJ-2] · V000133 · Co-sponsored 2025-06-12
- Rep. Knott, Brad [R-NC-13] · [R-NC-13] · K000405 · Co-sponsored 2025-07-14
- Rep. Smith, Christopher H. [R-NJ-4] · [R-NJ-4] · S000522 · Co-sponsored 2025-07-17Rep-NJ-4 current · 23 terms · 2 district offices
- Rep. Thompson, Mike [D-CA-4] · [D-CA-4] · T000460 · Co-sponsored 2025-07-17
- Rep. Rouzer, David [R-NC-7] · [R-NC-7] · R000603 · Co-sponsored 2025-07-21
- Rep. Simpson, Michael K. [R-ID-2] · [R-ID-2] · S001148 · Co-sponsored 2025-07-21
- Rescom. Hernández, Pablo Jose [D-PR-At Large] · [D-PR-0] · H001103 · Co-sponsored 2025-07-21
- Rep. Tokuda, Jill N. [D-HI-2] · [D-HI-2] · T000487 · Co-sponsored 2025-07-23
- Rep. Grothman, Glenn [R-WI-6] · [R-WI-6] · G000576 · Co-sponsored 2025-07-29
- Rep. Gray, Adam [D-CA-13] · [D-CA-13] · G000605 · Co-sponsored 2025-07-29
- Rep. Bentz, Cliff [R-OR-2] · [R-OR-2] · B000668 · Co-sponsored 2025-08-01
- Rep. Min, Dave [D-CA-47] · [D-CA-47] · M001241 · Co-sponsored 2025-08-12Dem-CA-47 current · 1 term · 1 district office
- Rep. Carter, Earl L. "Buddy" [R-GA-1] · [R-GA-1] · C001103 · Co-sponsored 2025-08-15
- Rep. Letlow, Julia [R-LA-5] · [R-LA-5] · L000595 · Co-sponsored 2025-08-19
- Rep. Baird, James R. [R-IN-4] · [R-IN-4] · B001307 · Co-sponsored 2025-08-19
- Rep. Scholten, Hillary J. [D-MI-3] · [D-MI-3] · S001221 · Co-sponsored 2025-08-29
- Rep. Kim, Young [R-CA-40] · [R-CA-40] · K000397 · Co-sponsored 2025-09-02
- Rep. Van Duyne, Beth [R-TX-24] · [R-TX-24] · V000134 · Co-sponsored 2025-09-08
- Rep. Weber, Randy K. Sr. [R-TX-14] · [R-TX-14] · W000814 · Co-sponsored 2025-09-09
- Rep. Nunn, Zachary [R-IA-3] · [R-IA-3] · N000193 · Co-sponsored 2025-09-09
- Rep. McDonald Rivet, Kristen [D-MI-8] · [D-MI-8] · M001237 · Co-sponsored 2025-09-09
- Rep. Nehls, Troy E. [R-TX-22] · [R-TX-22] · N000026 · Co-sponsored 2025-09-09
- Rep. Van Orden, Derrick [R-WI-3] · [R-WI-3] · V000135 · Co-sponsored 2025-09-09
- Rep. Budzinski, Nikki [D-IL-13] · [D-IL-13] · B001315 · Co-sponsored 2025-09-10
- Rep. McBride, Sarah [D-DE-At Large] · [D-DE-0] · M001238 · Co-sponsored 2025-09-11Dem-DE current · 1 term · 1 district office
- Rep. Lucas, Frank D. [R-OK-3] · [R-OK-3] · L000491 · Co-sponsored 2025-09-15
- Rep. Jackson, Ronny [R-TX-13] · [R-TX-13] · J000304 · Co-sponsored 2025-09-19
- Rep. Fischbach, Michelle [R-MN-7] · [R-MN-7] · F000470 · Co-sponsored 2025-09-26
- Rep. Kennedy, Timothy M. [D-NY-26] · [D-NY-26] · K000402 · Co-sponsored 2025-09-30
- Rep. Evans, Gabe [R-CO-8] · [R-CO-8] · E000300 · Co-sponsored 2025-10-17
- Rep. Schrier, Kim [D-WA-8] · [D-WA-8] · S001216 · Co-sponsored 2025-10-17
- Rep. Schmidt, Derek [R-KS-2] · [R-KS-2] · S001228 · Co-sponsored 2025-10-17
- Rep. Lofgren, Zoe [D-CA-18] · [D-CA-18] · L000397 · Co-sponsored 2025-12-04
- Rep. Riley, Josh [D-NY-19] · [D-NY-19] · R000622 · Co-sponsored 2025-12-09Dem-NY-19 current · 1 term · 2 district offices
- Rep. Garamendi, John [D-CA-8] · [D-CA-8] · G000559 · Co-sponsored 2025-12-17
- Rep. Vasquez, Gabe [D-NM-2] · [D-NM-2] · V000136 · Co-sponsored 2026-01-06
- Rep. Perez, Marie Gluesenkamp [D-WA-3] · [D-WA-3] · G000600 · Co-sponsored 2026-01-07
- Rep. DesJarlais, Scott [R-TN-4] · [R-TN-4] · D000616 · Co-sponsored 2026-02-09
- Rep. Ivey, Glenn [D-MD-4] · [D-MD-4] · I000058 · Co-sponsored 2026-02-11
- Rep. Bergman, Jack [R-MI-1] · [R-MI-1] · B001301 · Co-sponsored 2026-02-24
- Rep. Foushee, Valerie P. [D-NC-4] · [D-NC-4] · F000477 · Co-sponsored 2026-02-26
- Rep. Alford, Mark [R-MO-4] · [R-MO-4] · A000379 · Co-sponsored 2026-03-03
- Rep. Langworthy, Nicholas A. [R-NY-23] · [R-NY-23] · L000600 · Co-sponsored 2026-03-20
- Rep. Trahan, Lori [D-MA-3] · [D-MA-3] · T000482 · Co-sponsored 2026-03-26
- Rep. Moore, Tim [R-NC-14] · [R-NC-14] · M001236 · Co-sponsored 2026-03-30
- Rep. Gottheimer, Josh [D-NJ-5] · [D-NJ-5] · G000583 · Co-sponsored 2026-04-06
- Rep. Edwards, Chuck [R-NC-11] · [R-NC-11] · E000246 · Co-sponsored 2026-04-16
- Rep. Gillen, Laura [D-NY-4] · [D-NY-4] · G000602 · Co-sponsored 2026-04-27
- Rep. Mackenzie, Ryan [R-PA-7] · [R-PA-7] · M001230 · Co-sponsored 2026-05-11
- Rep. Biggs, Sheri [R-SC-3] · [R-SC-3] · B001325 · Co-sponsored 2026-06-04
- Rep. Joyce, John [R-PA-13] · [R-PA-13] · J000302 · Co-sponsored 2026-06-18
- Rep. Goldman, Craig A. [R-TX-12] · [R-TX-12] · G000601 · Co-sponsored 2026-06-24
- Rep. De La Cruz, Monica [R-TX-15] · [R-TX-15] · D000594 · Co-sponsored 2026-06-30
- Rep. Peters, Scott H. [D-CA-50] · [D-CA-50] · P000608 · Co-sponsored 2026-06-30
- Rep. Titus, Dina [D-NV-1] · [D-NV-1] · T000468 · Co-sponsored 2026-07-21
- Rep. Goodlander, Maggie [D-NH-2] · [D-NH-2] · G000604 · Co-sponsored 2026-08-24
- Rep. Horsford, Steven [D-NV-4] · [D-NV-4] · H001066 · Co-sponsored 2026-09-14
Committees (2)
+
- Judiciary Committee [House Standing]2026-09-14T19:28:10ZDischarged From2025-02-12T15:02:20ZReferred To
- Energy and Commerce Committee [House Standing]2026-09-14T19:27:53ZReported By2026-07-21T16:45:00ZMarkup By2026-07-20T16:44:51ZMarkup By2025-02-12T15:02:15ZReferred To↳ Health Subcommittee
Actions — from XML (22)
+
- 2026-09-16Calendarsvia SenateReceived in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623.
- 2026-09-15 19:24:44FloorH38310via House floor actionsMotion to reconsider laid on the table Agreed to without objection.
- 2026-09-15 19:24:39FloorH37300via House floor actionsOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5671-5672)
- 2026-09-15 19:24:39Floor8000via Library of CongressPassed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
- 2026-09-15 19:14:24FloorH8D000via House floor actionsDEBATE - The House proceeded with forty minutes of debate on H.R. 1266.
- 2026-09-15 19:14:23FloorH30000via House floor actionsConsidered under suspension of the rules. (consideration: CR H5671-5673)
- 2026-09-15 19:13:56FloorH30300via House floor actionsMr. Guthrie moved to suspend the rules and pass the bill, as amended.
- 2026-09-14CalendarsH12410via House floor actionsPlaced on the Union Calendar, Calendar No. 715.
- 2026-09-14DischargeH12300via House floor actionsCommittee on the Judiciary discharged.
- 2026-09-14Committee5500via Library of CongressCommittee on the Judiciary discharged.
- 2026-09-14CommitteeH12200via House floor actionsReported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-816, Part I.
- 2026-09-14Committee5000via Library of CongressReported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-816, Part I.
- 2026-07-21Committeevia House committee actionsOrdered to be Reported in the Nature of a Substitute by the Yeas and Nays: 48 - 0.
- 2026-07-21Committeevia House committee actionsCommittee Consideration and Mark-up Session Held
- 2026-07-20Committeevia House committee actionsCommittee Consideration and Mark-up Session Held
- 2026-06-25Committeevia House committee actionsForwarded by Subcommittee to Full Committee by Voice Vote.
- 2026-06-25Committeevia House committee actionsSubcommittee Consideration and Mark-up Session Held
- 2025-02-12Committeevia House committee actionsReferred to the Subcommittee on Health.
- 2025-02-12IntroReferralH11100via House floor actionsReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-02-12IntroReferralH11100via House floor actionsReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-02-12IntroReferralIntro-Hvia Library of CongressIntroduced in House
- 2025-02-12IntroReferral1000via Library of CongressIntroduced in House
Actions — from bill_actions table (0)
+
Titles
+
- Short Title(s) from PCS (Placed on Senate Calendar) bill textPCSS2026-09-22T05:38:23ZCombating Illicit Xylazine Act
- Display Title2026-09-19T23:32:46ZCombating Illicit Xylazine Act
- Short Title(s) as Passed HouseEHH2026-09-17T04:38:39ZCombating Illicit Xylazine Act
- Official Title from EH (Engrossed in House) bill textEHH2026-09-17T04:38:39ZTo prohibit certain uses of xylazine, and for other purposes.
- Short Title(s) as Reported to HouseRHH2026-09-16T06:08:25ZCombating Illicit Xylazine Act
- Short Title(s) as IntroducedIH2025-03-13T15:23:21ZCombating Illicit Xylazine Act
- Official Title as IntroducedIH2025-03-13T15:18:30ZTo prohibit certain uses of xylazine, and for other purposes.
Text versions (from XML)
+
- Placed on Calendar Senate2026-09-16T04:00:00Z
- Engrossed in House2026-09-15T04:00:00Z
- Reported in House2026-09-14T04:00:00Z
- Introduced in House2025-02-12T05:00:00Z
Versions — from bill_versions table (0)
+
Policy area
+
Summaries
+
Combating Illicit Xylazine Act
This bill regulates xylazine under the Controlled Substances Act (CSA).
Xylazine, also known as tranq, is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine.
This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused.
Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA.
The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife programs.
The bill also exempts xylazine manufacturers from the CSA's physical security requirements.
Finally, the bill requires the DEA, in coordination with the Food and Drug Administration, to report on (1) the prevalence and impact of illicit xylazine use in the United States, and (2) updated information on the prevalence and proliferation of xylazine trafficking and misuse in the United States.
Related bills
+
- S 545 (119) Combating Illicit Xylazine ActLatest: 2026-04-15 — Placed on Senate Legislative Calendar under General Orders. Calendar No. 372.Relationship: Related bill (via House), Related bill (via CRS)
Amendments (0)
+
Laws
+
Committee reports
+
- H. Rept. 119-816
Calendar number
+
CBO cost estimates
+
Latest action
+
Dublin Core
+
Row fields (debug)
- id
- 2527
- congress
- 119
- bill_type
- hr
- bill_number
- 1266
- bill_slug
- hr-1266-119
- title
- Combating Illicit Xylazine Act
- short_title
- Combating Illicit Xylazine Act
- sponsor_bioguide_id
- P000613
- sponsor_name
- Rep. Panetta, Jimmy [D-CA-19]
- sponsor_party
- D
- sponsor_state
- CA
- introduced_date
- 2025-02-12
- latest_action_date
- 2026-09-16
- latest_action_text
- Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623.
- status
- null
- policy_area
- Crime and Law Enforcement
- subjects_json
[ "Congressional oversight", "Consumer affairs", "Criminal procedure and sentencing", "Drug safety, medical device, and laboratory regulation", "Drug trafficking and controlled substances", "Licensing and registrations", "Manufacturing", "U.S. Sentencing Commission", "Veterinary medicine and animal diseases" ]
- govinfo_billstatus_path
- BILLSTATUS-119hr1266
- raw_billstatus_xml
- <?xml version="1.0" encoding="utf-8" standalone="no"?> <billStatus> <version>3.0.0</version> <bill> <number>1266</number> <updateDate>2026-10-31T02:42:10Z</updateDate> <updateDateIncludingText>2026-10-31T02:42:10Z</updateDateIncludingText> <originChamber>House</originChamber> <originChamberCode>H</originChamberCode> <type>HR</type> <introducedDate>2025-02-12</int…
- summary_lede
- This bill regulates xylazine under the Controlled Substances Act (CSA). Xylazine, also known as tranq , is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine. This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule …
- topic_primary
- justice
- topic_secondary_json
[]
- action_family
- introduced_only
- response_available
- 0
- response_type
- null
- response_deadline
- null
- importance_score
- null
- consequence_score
- null
- urgency_score
- null
- overall_score
- null
- in_canopy
- 0
- canopy_expires_at
- null
- pipeline_track
- federal_presidential
- pipeline_stage
- passed_origin
- pipeline_stage_rank
- 2
- stable_action_id
- hr-1266-119
- jurisdiction
- federal
- lock_status
- open
- lock_at
- null
- content_hash
- 92bc3281c511f81be897fe9dfc24918dd3b2fef1be249b041983614c1c46f6f3
- anchored_at
- null
- anchor_merkle_root
- null
- source_kind
- api_fill
- first_seen_at
- 2026-04-20T08:15:57.988066+00:00
- last_seen_at
- 2026-11-07T12:30:28.847021+00:00
